270 related articles for article (PubMed ID: 6233779)
1. Chemotherapy of hormonally unresponsive prostatic carcinoma.
deKernion JB; Lindner A
Urol Clin North Am; 1984 May; 11(2):319-26. PubMed ID: 6233779
[TBL] [Abstract][Full Text] [Related]
2. [Chemotherapy of prostatic cancer].
Portnoĭ AS
Vopr Onkol; 1985; 31(9):3-12. PubMed ID: 2931901
[No Abstract] [Full Text] [Related]
3. [Radiation and drug therapy of prostatic cancer].
Matveev BP; Makarova GV; Bukharkin BV
Urol Nefrol (Mosk); 1986; (3):65-72. PubMed ID: 3090758
[No Abstract] [Full Text] [Related]
4. Experiences with estramustine phosphate (Estracyt, Emcyt) in prostate cancer.
Murphy GP; Slack NH; Mittelman A
Semin Oncol; 1983 Sep; 10(3 Suppl 3):34-42. PubMed ID: 6364365
[No Abstract] [Full Text] [Related]
5. Cytotoxic agents effective in prostate cancer.
Schmidt JD
Semin Urol; 1983 Nov; 1(4):299-310. PubMed ID: 6399616
[No Abstract] [Full Text] [Related]
6. [Chemotherapy for advanced pancreatic carcinoma].
Yokoyama T; Shimada Y
Gan To Kagaku Ryoho; 1992 Dec; 19(14):2338-43. PubMed ID: 1463339
[TBL] [Abstract][Full Text] [Related]
7. The chemotherapy of prostatic adenocarcinoma.
Torti FM; Carter SK
Ann Intern Med; 1980 May; 92(5):681-9. PubMed ID: 6992675
[TBL] [Abstract][Full Text] [Related]
8. [Chemotherapy of stomach cancer].
Gropp C; Havemann K
Z Gastroenterol; 1982 Dec; 20(12):703-9. PubMed ID: 6819730
[TBL] [Abstract][Full Text] [Related]
9. [Polychemotherapy and radiotherapy for small cell cancer of the lung].
Linchenko IF; Danil'ian VM
Vopr Onkol; 1983; 29(9):106-14. PubMed ID: 6314659
[No Abstract] [Full Text] [Related]
10. [Chemotherapy of breast cancers. Coordinated evolution of therapeutic schemes from 1975 to 1985].
Chauvergne J; Durand M; Mauriac L; Hoerni B; David M
Rev Fr Gynecol Obstet; 1986 Mar; 81(3):119-22. PubMed ID: 3085195
[TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy of hormone-unresponsive prostatic cancer and its metastatic foci].
Kotake T
Gan To Kagaku Ryoho; 1982 Mar; 9(3):387-96. PubMed ID: 6764105
[TBL] [Abstract][Full Text] [Related]
12. Resume of selected studies of the National Bladder Cancer Collaborative Group A and new protocols.
Prout GR; Kopp J
Prog Clin Biol Res; 1984; 162B():397-427. PubMed ID: 6438644
[No Abstract] [Full Text] [Related]
13. Value of cyclophosphamide or melphalan as combined chemotherapy in hormonally unresponsive prostatic carcinoma.
Graham SD; Walker A; Cox EB; Laszlo J; Berry WR; Paulson DF
Urology; 1986 Nov; 28(5):404-8. PubMed ID: 3538611
[TBL] [Abstract][Full Text] [Related]
14. [Current views of the treatment of non-microcellular carcinoma of the lungs].
Swierz J
Wiad Lek; 1985 Jun; 38(11):783-9. PubMed ID: 3901531
[No Abstract] [Full Text] [Related]
15. National randomized study of chemotherapeutic agents in advanced prostatic carcinoma: a progress report.
Johnson DE; Scott WW; Gibbons RP; Prout GR; Schmidt JD; Chu TM; Gaeta J; Saroff J; Murphy GP
Cancer Treat Rep; 1977; 61(2):317-23. PubMed ID: 141326
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
Thigpen T; Vance R; Puneky L; Khansur T
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of rotating chemotherapy in advanced breast cancer. An Eastern Cooperative Oncology Group Trial.
Tormey D; Gelman R; Falkson G
Am J Clin Oncol; 1983 Feb; 6(1):1-18. PubMed ID: 6340458
[No Abstract] [Full Text] [Related]
18. Chemotherapy of hormone-resistant stage D prostatic cancer.
Schmidt JD
J Urol; 1980 Jun; 123(6):797-805. PubMed ID: 7189791
[No Abstract] [Full Text] [Related]
19. Randomized trial of combination chemotherapy in hormone-resistant metastatic prostate carcinoma.
Page JP; Levi JA; Woods RL; Tattersall MN; Fox RM; Coates AS
Cancer Treat Rep; 1985 Jan; 69(1):105-7. PubMed ID: 3881176
[TBL] [Abstract][Full Text] [Related]
20. Oral estramustine and cyclophosphamide in patients with metastatic hormone refractory prostate carcinoma: a phase II study.
Bracarda S; Tonato M; Rosi P; De Angelis V; Mearini E; Cesaroni S; Fornetti P; Porena M
Cancer; 2000 Mar; 88(6):1438-44. PubMed ID: 10717628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
